Jones Financial Companies
ICCC icon

Jones Financial Companies’s ImmuCell ICCC Stock Holding History

Jones Financial Companies’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$124 Hold
19
– – ﹤0.01% 4627
2025
Q4 		$117 Hold
19
– – ﹤0.01% 4305
2025
Q3 		$115 Hold
19
– – ﹤0.01% 4156
2025
Q2 		$128 Hold
19
– – ﹤0.01% 3940
2025
Q1 		$95 Hold
19
– – ﹤0.01% 3630
2024
Q4 		$98 Hold
19
– – ﹤0.01% 3353
2024
Q3 		$67 Hold
19
– – ﹤0.01% 2986
2024
Q2 		$92 Buy
+19
New +$91 ﹤0.01% 2395

Other funds holding ICCC

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

Jones Financial Companies's ICCC Position: Q1 2026 in Review

Jones Financial Companies held its ImmuCell (ICCC) position steady in Q1 2026 at 19 shares worth $124. The position accounts for ﹤0.01% of the portfolio, ranked #4627.

Jones Financial Companies first reported a position in ICCC in Q2 2024 and has held it in 8 quarters since. The position peaked at $128 in Q2 2025. 27 funds tracked by Wall St. Rank hold ICCC as of Q1 2026.

  • Jones Financial Companies held 19 shares of ImmuCell worth $124 as of Q1 2026.
  • Jones Financial Companies left its ImmuCell share count unchanged in Q1 2026.
  • ImmuCell made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4627 holding.
  • Jones Financial Companies first reported a position in ImmuCell in Q2 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's ImmuCell position peaked at $128 in Q2 2025.
  • 27 funds tracked by Wall St. Rank held ImmuCell as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.